Stockreport

Rafael Holdings and Cyclo Therapeutics Enter Into a Definitive Merger Agreement [Yahoo! Finance]

Rafael Holdings, Inc. Class B  (RFL) 
NASDAQ:AMEX Investor Relations: morningstar.com/funds/xnas/rytnx/quote.html
PDF genetic disease, is fully enrolled and results from the 48-week interim analysis are expected in the middle of 2025 NEWARK, N.J. & GAINESVILLE, Fla., August 22, 2024 B [Read more]